Clinical Trials Browser

INDUSTRY × navitoclax × Thoracic × Clear all

NCT00445198 2018-06-06

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Phase 1/2 Completed

Small Cell Lung Carcinoma